Ethyl Acetate

Ethyl Acetate

SCHEMBL1121012

CCOC(C)=O.ClC(Cl)Cl.ClC(Cl)Cl.ClC(Cl)Cl

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.78
▸ LMNA P02545 1/20 0.78
▸ HSD17B10 Q99714 1/20 0.78
▸ TSHR P16473 1/20 0.48
▸ GAA P10253 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ MGAM O43451 1/20 0.43
▸ SI P14410 1/20 0.43
▸ MGAM2 Q2M2H8 1/20 0.43
▸ SOAT1 P35610 1/20 0.43
▸ TRPA1 O75762 1/20 0.40
▸ GLO1 Q04760 1/20 0.39
▸ CA12 O43570 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ CHRM5 P08912 2/20 0.37
▸ CHRM1 P11229 2/20 0.37
▸ CHRM3 P20309 2/20 0.37
▸ PGR P06401 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL5694224 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL697797 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL4011115 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL736472 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1919444 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL284481 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1671817 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1577562 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1121229 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL7573225 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158647-A1 PHOTOCHROMIC CURABLE COMPOSITION TOKUYAMA CORPORATION (JP) 2024-05-16 — — US disclosed
CN-116997829-A Photochromic curable composition 株式会社德山 2023-11-03 — — CN disclosed
CN-116940871-A Photochromic curable composition, photochromic laminate, and method for producing same 株式会社德山 2023-10-24 — — CN disclosed
EP-2769998-B1 (METH)ACRYLATE COMPOUND, AND PHOTOCHROMIC CURABLE COMPOSITION CONTAINING SAID (METH)ACRYLATE COMPOUND TOKUYAMA CORP (JP) 2016-08-03 — — EP disclosed
CN-103906774-B (methyl) acrylic compound and comprise the photochromic curable composition of this (methyl) acrylic compound TOKUYAMA CORP. (JP) 2016-01-06 — — CN disclosed
US-9162988-B2 Therapeutic or prophylactic agent for allergic dermatitis TORAY INDUSTRIES, INC. (JP) 2015-10-20 — — US disclosed
CN-102516093-B Gemini type asphalt emulsifier and preparation method thereof JIANGSU BOTE NEW MATERIALS CO., LTD. (CN) 2014-10-08 — — CN disclosed
EP-2769998-A1 (METH)ACRYLATE COMPOUND, AND PHOTOCHROMIC CURABLE COMPOSITION CONTAINING SAID (METH)ACRYLATE COMPOUND Tokuyama Corporation (JP) 2014-08-27 — — EP disclosed
US-20140203226-A1 (METH)ACRYLATE COMPOUND AND PHOTOCHROMIC CURABLE COMPOSITION CONTAINING THE (METH)ACRYLATE COMPOUND TOKUYAMA CORPORATION (JP) 2014-07-24 — — US disclosed
CN-103906774-A (meth)acrylate compound, and photochromic curable composition containing said (meth)acrylate compound TOKUYAMA CORPROATION 2014-07-02 — — CN disclosed
US-5739131-A TREATMENT OF KIDNEY DISORDERS; COMPOUNDS DO NOT AFFECT BLOOD PRESSURE KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 1998-04-14 — — US disclosed
US-5731310-A KIDNEY DISEASE KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 1998-03-24 — — US disclosed
EP-0820995-A1 Novel sesquiterpene derivatives having progesterone receptor binding inhibitory activity and process for producing the same Meiji Seika Kaisha, Ltd. (JP) 1998-01-28 — — EP disclosed
US-5696118-A ADMINISTERING FOR TREATING KIDNEY DISEASE KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 1997-12-09 — — US disclosed
EP-0747352-A1 CYCLIC NITROGENOUS COMPOUND AND HERBICIDE NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1996-12-11 — — EP disclosed
US-5496503-A DIOLS WITH AMINE GROUPS AND DOUBLE BOND, AZO OR IMINE GROUPS IN BACKBONE, POLYURETHANES, POLYESTERS NIPPON TELEGRAPH AND TELEPHONE (JP) 1996-03-05 — — US disclosed
EP-0685470-A2 Benzene derivatives and pharmaceutical composition Kureha Chemical Industry Co., Ltd. (JP) 1995-12-06 — — EP disclosed
US-5268442-A Chiral copolymers with oligosiloxane spacers BRIGHAM YOUNG UNIVERSITY (US) 1993-12-07 — — US disclosed
EP-0213610-A1 Azetidin-2-one derivatives and process for production thereof LEDERLE (JAPAN) LTD. (JP) 1987-03-11 — — EP disclosed
US-4473632-A DYE RELEASING REDOX COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1984-09-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140203226-A1 (METH)ACRYLATE COMPOUND AND PHOTOCHROMIC CURABLE COMPOSITION CONTAINING THE (METH)ACRYLATE COMPOUND TET1, MGMT, CRYAA ALDH1A1 303/4885LMNA 767/4885HSD17B10 3440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback